UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 205

Sortiert nach

Linearity of pharmacokinetics and model estimation of sufentanil

Anesthesiology (Philadelphia), 1995-12, Vol.83 (6), p.1194-1204

1995

Volltextzugriff (PDF)

Absorption, metabolism, and excretion of risperidone in humans

Drug metabolism and disposition, 1993-11, Vol.21 (6), p.1134

1993

Volltextzugriff (PDF)

Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat

Psychopharmacologia, 1994-02, Vol.114 (1), p.53-62

1994

Volltextzugriff (PDF)

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

Chemical research in toxicology, 1992-03, Vol.5 (2), p.211-219

1992

Volltextzugriff (PDF)

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man

Psychopharmacologia, 1995-12, Vol.122 (3), p.223-229

1995

Volltextzugriff (PDF)

Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co‐medication interactions

British journal of pharmacology, 2000-04, Vol.129 (8), p.1655-1667

2000

Volltextzugriff (PDF)

Effect of Food on the Pharmacokinetics of a New Hydroxypropyl-β-Cyclodextrin Formulation of Itraconazole

Pharmacotherapy, 1996-05, Vol.16 (3), p.424-428

1996

Volltextzugriff (PDF)

Posttreatment itraconazole levels in the nail

Journal of the American Academy of Dermatology, 1992-05, Vol.26 (5), p.731-735

1992

Volltextzugriff (PDF)

Pharmacokinetic profile of orally administered itraconazole in human skin

Journal of the American Academy of Dermatology, 1988-02, Vol.18 (2), p.263-268

1988

Volltextzugriff (PDF)

Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans

Drug metabolism and disposition, 1995-03, Vol.23 (3), p.354

1995

Volltextzugriff (PDF)

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

Antimicrobial Agents and Chemotherapy, 1993-10, Vol.37 (10), p.2224-2227

1993

Volltextzugriff (PDF)

The Clinical Pharmacokinetics of Itraconazole: An Overview

Mycoses, 1989-11, Vol.32 (s1), p.67-87

1989

Volltextzugriff (PDF)

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

Journal of the American Academy of Dermatology, 1992-05, Vol.26 (5 Pt 1), p.731

1992

Volltextzugriff (PDF)

The metabolism and excretion of risperidone after oral administration in rats and dogs

Drug metabolism and disposition, 1994-01, Vol.22 (1), p.129

1994

Volltextzugriff (PDF)

The pharmacokinetics of sufentanil in surgical patients

Anesthesiology (Philadelphia), 1984-11, Vol.61 (5), p.502-506

1984

Volltextzugriff (PDF)

The effects of food and dose of the oral systemic availability of itraconazole in healthy subjects

European journal of clinical pharmacology, 1989-07, Vol.36 (4), p.423-426

1989

Volltextzugriff (PDF)

Assay methods for sufentanil in plasma : radioimmunoassay versus gas chromatography-mass spectrometry

Anesthesiology (Philadelphia), 1994-03, Vol.80 (3), p.666-670

1994

Volltextzugriff (PDF)

Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog

Drug metabolism and disposition, 1995-02, Vol.23 (2), p.216

1995

Volltextzugriff (PDF)

Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man

Journal of pharmacy and pharmacology, 1983-02, Vol.35 (2), p.86-93

1983

Volltextzugriff (PDF)

Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro

The Journal of pharmacology and experimental therapeutics, 1992-08, Vol.262 (2), p.699

1992

Volltextzugriff (PDF)

Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients

Anesthesiology (Philadelphia), 1987, Vol.66 (1), p.3-12

1987

Volltextzugriff (PDF)

Location of the hydroxyl functions in hydroxylated metabolites of nebivolol in different animal species and human subjects as determined by on-line high-performance liquid chromatography-diode-array detection

Journal of Chromatography A, 1996-04, Vol.729 (1), p.341-354

1996

Volltextzugriff (PDF)

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

Antimicrobial Agents and Chemotherapy, 1986-08, Vol.30 (2), p.206-210

1986

Volltextzugriff (PDF)

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

Antimicrobial Agents and Chemotherapy, 1990-03, Vol.34 (3), p.402-408

1990

Volltextzugriff (PDF)

Itraconazole pharmacokinetics in patients with renal dysfunction

Antimicrobial Agents and Chemotherapy, 1988-10, Vol.32 (10), p.1595-1597

1988

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(204)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linearity of pharmacokinetics and model estimation of sufentanil

Absorption, metabolism, and excretion of risperidone in humans

Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man

Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co‐medication interactions

Effect of Food on the Pharmacokinetics of a New Hydroxypropyl-β-Cyclodextrin Formulation of Itraconazole

Posttreatment itraconazole levels in the nail

Pharmacokinetic profile of orally administered itraconazole in human skin

Reduction of the prodrug loperamide oxide to its active drug loperamide in the gut of rats, dogs, and humans

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

The Clinical Pharmacokinetics of Itraconazole: An Overview

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

The metabolism and excretion of risperidone after oral administration in rats and dogs

The pharmacokinetics of sufentanil in surgical patients

The effects of food and dose of the oral systemic availability of itraconazole in healthy subjects

Assay methods for sufentanil in plasma : radioimmunoassay versus gas chromatography-mass spectrometry

Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog

Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man

Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro

Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients

Location of the hydroxyl functions in hydroxylated metabolites of nebivolol in different animal species and human subjects as determined by on-line high-performance liquid chromatography-diode-array detection

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

Itraconazole pharmacokinetics in patients with renal dysfunction

Suchergebnisse filtern